Corbus Pharmaceuticals Holdings Inc CRBP Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$2.86 down $0.71, 19.89% at close Nov 5
Last close · Previous close $3.57
- Market cap
- At the Nov 5 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$2.86down $0.71, 19.89%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$3.57Nov 4
- Volume1.36MNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.20MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $2.81 to $12.88; now $2.86
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
CRBP trailed the S&P 500 in all 7 periods.
| Period | CRBP and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | CRBP: down 51.1% S&P 500: down 5.4% | CRBP trailed the S&P 500 by 45.7 percentage points Trailed |
| 3M | CRBP: down 70.1% S&P 500: down 4.5% | CRBP trailed the S&P 500 by 65.6 percentage points Trailed |
| YTD | CRBP: down 64.9% S&P 500: up 8.3% | CRBP trailed the S&P 500 by 73.2 percentage points Trailed |
| 1Y | CRBP: down 73.8% S&P 500: up 9.3% | CRBP trailed the S&P 500 by 83.1 percentage points Trailed |
| Long term | ||
| 3Y | CRBP: down 45.3% S&P 500: up 74.8% −18.2% vs +20.5% a year | CRBP trailed the S&P 500 by 120.1 percentage points Trailed |
| 5Y | CRBP: down 90.7% S&P 500: up 67.3% −37.9% vs +10.8% a year | CRBP trailed the S&P 500 by 158.0 percentage points Trailed |
| 10Y | CRBP: down 98.0% S&P 500: up 311.8% −32.4% vs +15.2% a year | CRBP trailed the S&P 500 by 409.8 percentage points Trailed |
$10,000 invested in CRBP 10 years ago (Nov 4, 2016) would be worth about $199 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,184.
CRBP trailed the S&P 500 in all 7 periods.
| Period | CRBP and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | CRBP: down 51.1% S&P 500: down 5.4% | CRBP trailed the S&P 500 by 45.7 percentage points Trailed |
| 3M | CRBP: down 70.1% S&P 500: down 4.8% | CRBP trailed the S&P 500 by 65.3 percentage points Trailed |
| YTD | CRBP: down 64.9% S&P 500: up 7.5% | CRBP trailed the S&P 500 by 72.4 percentage points Trailed |
| 1Y | CRBP: down 73.8% S&P 500: up 8.2% | CRBP trailed the S&P 500 by 82.0 percentage points Trailed |
| Long term | ||
| 3Y | CRBP: down 45.3% S&P 500: up 68.6% −18.2% vs +19.0% a year | CRBP trailed the S&P 500 by 113.9 percentage points Trailed |
| 5Y | CRBP: down 90.7% S&P 500: up 56.4% −37.9% vs +9.4% a year | CRBP trailed the S&P 500 by 147.1 percentage points Trailed |
| 10Y | CRBP: down 98.0% S&P 500: up 251.5% −32.4% vs +13.4% a year | CRBP trailed the S&P 500 by 349.5 percentage points Trailed |
$10,000 invested in CRBP 10 years ago (Nov 4, 2016) would be worth about $199 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,147.
All-time high
$310.50
Closing high on . Now 99.1% below that record.
Split-adjusted daily closes since Nov 11, 2014.
Stock splits
1
1-for-30 on . Share counts adjust after each split.
Valuation
Financials
About Corbus Pharmaceuticals Holdings Inc
Corbus Pharmaceuticals Holdings, Inc. is an oncology and obesity company with a diversified portfolio and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways. Corbus’ pipeline includes CRB-701, a next generation antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody which blocks the activation of TGFβ expressed on cancer cells, and CRB-913, a highly peripherally restricted CB1 receptor inverse agonist for the treatment of obesity. Corbus is headquartered in Norwood, Massachusetts.
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
CRBP news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
CRBP stock FAQ
What is CRBP stock’s price today?
Corbus Pharmaceuticals Holdings (CRBP) traded at $2.86 at the close on , down $0.71 (19.89%) from the previous close of $3.57. Over the past 52 weeks it has traded between $2.81 and $12.88.
If you invested $1,000 in CRBP 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in CRBP on would be worth about $20 at the close on , a total return of −98.0%. The same $1,000 would be worth $93 if invested five years ago and $262 if invested one year ago. Past performance doesn’t predict future returns.
Does CRBP pay a dividend?
Corbus Pharmaceuticals Holdings hasn’t paid a dividend in the last twelve months.
What is CRBP’s 52-week high and low?
Over the past 52 weeks CRBP has traded as low as $2.81 and as high as $12.88. At $2.86 at the close on , it is 77.8% below that high and 1.8% above the low.
What is CRBP’s all-time high?
CRBP’s highest closing price was $310.50 on , adjusted for stock splits. At $2.86 at the close on , it is 99.1% below that record.
Has CRBP stock ever split?
Yes, once: 1-for-30 on .
How has CRBP stock performed?
Including dividends and measured to the close on , CRBP has returned −64.9% so far this year and −73.8% over the past year, and −90.7% over five years (−37.9% a year). Over the same periods the S&P 500, measured by SPY, returned +8.3%, +9.3% and +67.3%. Past performance doesn’t predict future returns.
What exchange does CRBP trade on?
Corbus Pharmaceuticals Holdings trades on the Nasdaq under the ticker symbol CRBP. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.